Overview of Aging Research
Aging is a universal trait and a key risk factor for a variety of human diseases, and it is critical to identify the cellular and molecular mechanisms of aging and age-related diseases.
Current research focuses on high-throughput sequencing and bioinformatics approaches to help unravel the molecular mechanisms of aging, longevity and age-related diseases, identify aging biomarkers, construct age clocks to distinguish between real age and biological age, and progressively expand a more comprehensive understanding of aging.
Services We Provide
CD BioSciences is an integrated biotechnology company offering a wide range of professional services. Longevity, its subsidiary, is focused on providing a high quality and reliable biological age clock technology platform for longevity research to advance your aging research.
We utilize DNA methylation, telomere measurement, transcriptome, proteome, metabolome and other aging clock technologies to provide aging research services to our global customers, contributing to the continued development of aging and related drug research. As experts in the field of aging, we provide our clients with a complete system of aging research technologies to provide only the highest quality technical services.
DNA Methylation Research in Aging
High-throughput, high-precision and affordable DNA methylation analysis services in aging studiesLearn More
Telomere Length Research in Aging
Technical platform for telomere length measurement and telomere related research servicesLearn More
Omics Research in Aging
Genomic, transcriptomic, proteomic, and metabolomic approaches integrate different types of aging dataLearn More
Reverse Aging Research
Reversal therapies research services on reversing agingLearn More
Innovative technology platform
Multiple omics and age-clock techniques allow the aging process to be studied from multiple perspectives, each complementing and validating the results.
Bioinformatics methods support
The results of various omics studies can be subjected to high-throughput bioinformatics analysis, greatly reducing the experimental cycle time.
Both basic research and application development are available
Our best-in-class technology and infrastructure build the basic research framework that strongly supports pharmaceutical companies' therapy development.
Our services are for research use only and not for any clinical use.
We are a comprehensive technology platform company integrating aging DNA methylation, telomere, transcriptome, proteome, and metabolome research.